Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Close this folder6. Planning bulletin production: schedules and timing
View the document6.1 Why is planning necessary?
View the document6.2 Start modestly and grow gradually
View the document6.3 Develop a framework for producing articles
View the document6.4 Flexible planning for each issue
View the document6.5 Allow time for delays in distribution
View the document6.6 Integrate necessary sidelines into your overall planning
View the document6.7 A few principles for planning the production of a bulletin
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

6.6 Integrate necessary sidelines into your overall planning

Some of the editorial team’s activities take time, but are often neglected in overall planning. These may include, for example, acknowledgements and follow-up letters to reviewers, follow-up of letters to the editors, which sometimes require a correction or erratum in the next issue and resolution of conflicts with pharmaceutical companies (or their opinion leaders) or other institutions. The team may also prepare an annual index of drugs and topics covered in each bulletin (this work can be made easier by building the index over time by adding new entries each time a new issue is prepared).

Some of these activities can be planned for in advance, for example the preparation of the index and follow-up with reviewers. Others are unpredictable, but time needs to be set aside for them. If a bulletin is produced by a small editorial team, the editors may also be in charge of subscriptions, promotion or accounting. A realistic amount of time must of course be allowed for these time-consuming activities. There is no need to point out that financial planning and management - discussed in Chapter 5 - are also crucial.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014